Lung Cancer Trial for Sublobar Resection Reaches Primary Completion

A Phase 3 clinical trial investigating sublobar resection for Lung Cancer adenocarcinoma, NCT06031181, reached its primary completion milestone on 2026-01-01. The study enrolled 390 participants.

Background

Lung adenocarcinoma is a common type of lung cancer. For certain early-stage presentations, such as adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), surgical approaches are critical. Sublobar resection is a surgical technique that removes a smaller portion of the lung compared to a lobectomy. The use of intraoperative frozen section diagnosis allows for immediate pathological assessment during surgery, which can guide the extent of resection. This trial aims to confirm the therapeutic effectiveness of sublobar resection when AIS/MIA is diagnosed via this intraoperative method, potentially refining surgical standards for these specific lung cancer types.

Trial design

This Phase 3 study, known as ECTOP-1019, is investigating sublobar resection for patients with Lung Adenocarcinoma, specifically those diagnosed as adenocarcinoma in situ or minimally invasive adenocarcinoma by Frozen Section during surgery. The trial has an enrollment of 390 participants. The primary goal is to confirm the therapeutic effect of Sublobar Resection in this patient population.

What this means

The primary completion of this Phase 3 trial signifies that data collection for the study's main objectives has concluded. While no results are yet available, this milestone is a crucial step towards generating evidence that could inform surgical practices for patients with early-stage lung adenocarcinoma, particularly regarding the efficacy of sublobar resection guided by intraoperative frozen section diagnosis. The findings, once published, will be important for clinicians and patients considering treatment options for these specific lung cancer subtypes.

Source

Information regarding the primary completion of this trial was obtained from ClinicalTrials.gov, a public database of clinical studies. The record for study NCT06031181, titled "Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)", was updated with the primary completion date of 2026-01-01 on clinicaltrials.gov.